Global Neuroscience Antibodies and Assays Market Analysis Report 2020-2024 - Industry Growth Rate Projection With CAGR of Over 8% and Current Trends, Share, Size, Top Players With Its Type and Applications | Technavio

The neuroscience antibodies and assays market is poised to grow by USD 1.36 billion during 2020-2024, progressing at a CAGR of over 8% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201105005767/en/

Technavio has announced its latest market research report titled Global Neuroscience Antibodies and Assays Market 2020-2024 (Graphic: Business Wire).

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis

The report on the neuroscience antibodies and assays market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advances.

The neuroscience antibodies and assays market analysis includes product segment and geography landscape. This study identifies the advances in neuroscience instruments as one of the prime reasons driving the neuroscience antibodies and assays market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The neuroscience antibodies and assays market covers the following areas:

Neuroscience Antibodies and Assays Market Sizing

Neuroscience Antibodies and Assays Market Forecast

Neuroscience Antibodies and Assays Market Analysis

Companies Mentioned

• Abcam Plc
• Bio-Rad Laboratories Inc.
• Cell Signaling Technology Inc.
• F. Hoffmann-La Roche Ltd.
• GenScript Biotech Corp.
• Merck KGaA
• Rockland Immunochemicals Inc.
• Santa Cruz Biotechnology Inc.
• Tecan Group Ltd.
• Thermo Fisher Scientific Inc. 

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• 2.1 Preface
• 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics

• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market outlook
• Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

• Market segmentation by product
• Comparison by product
• Consumables - Market size and forecast 2019-2024
• Instruments - Market size and forecast 2019-2024
• Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

PART 09: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 10: MARKET TRENDS

• High growth potential in emerging countries
• Increasing focus on neurological disease research
• Advances in neuroscience instruments

PART 11: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 12: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abcam Plc
• Bio-Rad Laboratories Inc.
• Cell Signaling Technology Inc.
• F. Hoffmann-La Roche Ltd.
• GenScript Biotech Corp.
• Merck KGaA
• Rockland Immunochemicals, Inc.
• Santa Cruz Biotechnology, Inc.
• Tecan Group Ltd.
• Thermo Fisher Scientific Inc.

PART 13: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

PART 14: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201105005767/en/